CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study
Mease, Philip J., Jeka, Slawomir, Jaller, Juan Jose, Kitumnuaypong, Tasanee, Louthrenoo, Worawit, Mann, Herman, Matsievskaia, Galina, Soriano, Enrique R., Jia, Bin, Wang, Caihong, Nie, Jing, Hsia, EliLanguage:
english
Journal:
The Journal of Rheumatology
DOI:
10.3899/jrheum.161238
Date:
November, 2017
File:
PDF, 1.01 MB
english, 2017